| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H26N2O |
| Molecular Weight | 310.4332 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C=C1)N=CC=C2CCC[C@@H]3CCNC[C@@H]3C=C
InChI
InChIKey=XFXANHWIBFMEOY-JKSUJKDBSA-N
InChI=1S/C20H26N2O/c1-3-15-14-21-11-9-16(15)5-4-6-17-10-12-22-20-8-7-18(23-2)13-19(17)20/h3,7-8,10,12-13,15-16,21H,1,4-6,9,11,14H2,2H3/t15-,16+/m0/s1
| Molecular Formula | C20H26N2O |
| Molecular Weight | 310.4332 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Viqualine (also known as PK 5078) was developed as an antidepressant; however, it has never been marketed. Viqualine acts as an inhibitor of the serotonin reuptake and release and possesses diazepam-like actions. In addition, was studied the ability of this compound to reduce alcohol consumption and that was not an antidepressant effect.
